Literature DB >> 1360918

In vitro fertilization program based on programmed cycles monitored by ultrasound only.

V Vlaisavljevic1, B Kovacic, V Gavric.   

Abstract

OBJECTIVE: Programmed oocyte retrieval was performed in order to make the in vitro fertilization (IVF) program cheaper and work of the IVF team easier.
METHOD: In a group of 77 patients included in the IVF program, the menstrual cycle was modified with estrogen-progesterone contraceptive pills. For this reason, it was possible to start the stimulation protocol in all patients on the same day. The stimulation protocol was a combination of clomiphene (100 mg) for 5 days and HMG (150 IU) every other day. Cycles were monitored by ultrasound only. RESULT: The implantation rate per embryo transfer was 22.4%. The number of embryos per embryo transfer was low (2.6 +/- 1.4) and eliminated the need for cryopreservation. Fertilization rate (82%) and embryo transfer rate (87%) were high. The take home baby rate was 14.3%.
CONCLUSION: Seventy percent of all punctures were performed in 3 days in the middle of the week. In our conditions, programmed oocyte retrieval is associated with significant economic benefits.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360918     DOI: 10.1016/0020-7292(92)90661-2

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  3 in total

Review 1.  Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).

Authors:  Irene Kwan; Siladitya Bhattacharya; Angela Kang; Andrea Woolner
Journal:  Cochrane Database Syst Rev       Date:  2014-08-24

2.  The preovulatory serum estradiol pattern in natural IVF/ICSI cycles.

Authors:  M Reljic; V Vlaisavljević
Journal:  J Assist Reprod Genet       Date:  1999-11       Impact factor: 3.412

3.  Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).

Authors:  Irene Kwan; Siladitya Bhattacharya; Andrea Woolner
Journal:  Cochrane Database Syst Rev       Date:  2021-04-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.